BE812120A - Anthelminthique - Google Patents

Anthelminthique

Info

Publication number
BE812120A
BE812120A BE141857A BE141857A BE812120A BE 812120 A BE812120 A BE 812120A BE 141857 A BE141857 A BE 141857A BE 141857 A BE141857 A BE 141857A BE 812120 A BE812120 A BE 812120A
Authority
BE
Belgium
Prior art keywords
anthelminthique
Prior art date
Application number
BE141857A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE812120A publication Critical patent/BE812120A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE141857A 1973-03-12 1974-03-11 Anthelminthique BE812120A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2312134A DE2312134C2 (de) 1973-03-12 1973-03-12 Anthelmintikum

Publications (1)

Publication Number Publication Date
BE812120A true BE812120A (fr) 1974-09-11

Family

ID=5874496

Family Applications (1)

Application Number Title Priority Date Filing Date
BE141857A BE812120A (fr) 1973-03-12 1974-03-11 Anthelminthique

Country Status (14)

Country Link
US (1) US3993759A (fr)
JP (1) JPS5740810B2 (fr)
BE (1) BE812120A (fr)
CA (1) CA1030068A (fr)
DD (1) DD110431A5 (fr)
DE (1) DE2312134C2 (fr)
EG (1) EG14407A (fr)
ES (1) ES424178A1 (fr)
FR (1) FR2221136B1 (fr)
GB (1) GB1408542A (fr)
IE (1) IE39045B1 (fr)
IL (1) IL44357A (fr)
NL (1) NL180069C (fr)
ZA (1) ZA741086B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303659A (en) * 1979-08-22 1981-12-01 Pfizer Inc. Schistosomicidal compositions
JPS6113121U (ja) * 1984-06-28 1986-01-25 シャープ株式会社 灯油気化バ−ナ−
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470062A1 (de) * 1964-02-06 1969-05-08 E Merck Ag Fa Verfahren zur Herstellung von 1,2,3,6,7,11 b-Hexahydro-4 H-pyrazino-[2,1-a]-isochinolinen
US3682926A (en) * 1971-04-19 1972-08-08 Archer Sydney Tetrahydroiso quinolinecarboxamides

Also Published As

Publication number Publication date
DE2312134C2 (de) 1983-05-05
IL44357A0 (en) 1974-06-30
ES424178A1 (es) 1976-09-01
NL180069B (nl) 1986-08-01
ZA741086B (en) 1975-01-29
AU6654674A (en) 1975-09-18
IE39045L (en) 1974-09-12
CA1030068A (fr) 1978-04-25
FR2221136A1 (fr) 1974-10-11
JPS49118823A (fr) 1974-11-13
NL7403228A (fr) 1974-09-16
IE39045B1 (en) 1978-07-19
IL44357A (en) 1977-02-28
GB1408542A (en) 1975-10-01
FR2221136B1 (fr) 1976-09-03
US3993759A (en) 1976-11-23
DD110431A5 (fr) 1974-12-20
NL180069C (nl) 1987-01-02
DE2312134A1 (de) 1974-09-19
JPS5740810B2 (fr) 1982-08-30
EG14407A (en) 1984-03-31

Similar Documents

Publication Publication Date Title
AT338352B (de) Ohrstuck
AT325093B (de) Trittbahn
BE811246A (fr) Quinoleine-3-carboxamidotetrazoles
ATA1023274A (de) Osteotom
AT329420B (de) Monoschi
AT325408B (de) Stoffloser
BE811495A (fr) Alpha-aminoacyl-3-halocephalosporines
BE809678A (fr) Vacuumschakelaar
BE808855A (fr) Sorbetiere
FI55555B (fi) Vaermeisolerad takbelaeggning
AT342382B (de) Flussmittel
AT354042B (de) Raffstore
BE811494A (fr) 3-halocephalosporines
BE808066A (fr) 1-aryloxy-2-propanolamines
ATA280876A (de) Fugizid
BE793744A (fr) Gewapend bouwpaneel
BE809458A (fr) Nitro-anthraquinones
BE806986A (fr) Stockeur-presentoir-dynamique
BE809206A (fr) Wagen
AT323390B (de) Türstock
BE812120A (fr) Anthelminthique
BE811546A (fr) Gasbrander
AT334322B (de) Ringbuch
BE810722A (fr) Benzo-difurannes
BE809430A (fr) Phenylalkanolamines

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK PATENT G.M.B.H.

Effective date: 19890331